Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study-Reference-Cited by-同舟云学术

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study

Published:2023-08 Issue:8 Volume:5 Page:100790
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Sonneveld Milan J.^ORCID,Chiu Shao-Ming,Park Jun Yong,Brakenhoff Sylvia M.,Kaewdech Apichat,Seto Wai-Kay,Tanaka Yasuhito,Carey Ivana,Papatheodoridi Margarita,Colombatto Piero,van Bömmel Florian,Berg Thomas,Zoulim Fabien,Ahn Sang Hoon,Dalekos George N.,Erler Nicole S.,Brunetto Maurizia,Wedemeyer Heiner,Cornberg Markus,Yuen Man-Fung,Agarwal Kosh,Boonstra Andre,Buti Maria,Piratvisuth Teerha,Papatheodoridis George,Chen Chien-Hung,Maasoumy Benjamin

Funder

Foundation for Liver and Gastrointestinal Research

Fujirebio Europe NV

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference18 articles.

1. Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians;Arends;Gut,2015

2. Prediction of sustained response after nucleo(s)tide analogue cessation using HBsAg and HBcrAg levels: a multicenter study (CREATE);Sonneveld;Clin Gastroenterol Hepatol,2020

3. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels;Sonneveld;J Hepatol,2022

4. Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapy;Papatheodoridi;J Viral Hepat,2022

5. Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B;Papatheodoridi;J Viral Hepat,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma surveillance after HBsAg seroclearance;Exploration of Digestive Diseases;2024-05-11

2. When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?;Current Hepatology Reports;2024-02-23

3. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy;Gastroenterology;2024-01